β3-AR activation can increase energy expenditure, fat breakdown, and improve insulin sensitivity, making it a potential therapeutic target for conditions like obesity and type 2 diabetes. This evidence concerns the gene ADRB3 and obesity due to melanocortin 4 receptor deficiency.